Among the most popular portfolio startups of the fund, we may highlight Vedanta Biosciences, Spinifex Pharmaceuticals. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Medical.
The high activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2015.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Symbiosis Group, startups are often financed by Seventure Partners, Rock Springs Capital, PureTech Health. The meaningful sponsors for the fund in investment in the same round are Uniseed Ventures, Shumway Capital, Partners Investment. In the next rounds fund is usually obtained by Uniseed Ventures, GBS Ventures, Brandon Capital Partners.
Related Funds
| Fund Name | Location |
| Blockrocket | Frankfurt, Germany, Hessen |
| CWB Startup Invest | China, Hong Kong, Hong Kong Island |
| DFE Capital Management | Arizona, Scottsdale, United States |
| Dongrun Xinyuan Keji | - |
| Huge Thing | Mazowieckie, Poland, Warszawa |
| Kakao Page | Kyonggi-do, Seongnam, South Korea |
| MC Capital | Coral Gables, Florida, United States |
| Neurosearch | Ballerup, Denmark, Hovedstaden |
| Parian Global Management | New York, New York, United States |
| Planet First Partners | England, London, United Kingdom |
| Reinforced Ventures | Pennsylvania, Pittsburgh, United States |
| Rochester Angel Network | New York, United States, West Henrietta |
| Saint-Gobain NOVA | Courbevoie, France, Ile-de-France |
| The Yomiuri Shimbun | Japan, Tokyo |
| Thought into Action Entrepreneurship Institute at Colgate University | Hamilton, New York, United States |
| Tianchen Touzi | China, Dongyang, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vedanta Biosciences | $18M | 13 May 2019 | Cambridge, Massachusetts, United States | ||
| $2M | 26 Jul 2005 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vedanta Biosciences | $18M | 13 May 2019 | Cambridge, Massachusetts, United States | ||
| $2M | 26 Jul 2005 | England |
